Onyinye Lovette Nomeh, Obodoechi Ijeoma Federica, Ofonmbuk Victor Joseph, Ezeh Chinonyelum Moneth, Rebecca Chinenye Ogba, Ohadoma Angela Nkechi, I. Peter, Peace Oluchi Akpu, C. I. Edemekong, I. Iroha
{"title":"产碳青霉烯酶大肠杆菌和肺炎克雷伯菌与尿路感染的检测","authors":"Onyinye Lovette Nomeh, Obodoechi Ijeoma Federica, Ofonmbuk Victor Joseph, Ezeh Chinonyelum Moneth, Rebecca Chinenye Ogba, Ohadoma Angela Nkechi, I. Peter, Peace Oluchi Akpu, C. I. Edemekong, I. Iroha","doi":"10.9734/ajrid/2023/v12i1234","DOIUrl":null,"url":null,"abstract":"Background and Objectives: Carbapenemase-producing bacteria are super bugs that make Urinary Tract Infections (UTIs) difficult to treat with drug of last resort such as carbapenem and other antibiotic thus limiting the treatment options. Carbapenemase production is increasing in clinical isolates of E. coli and K. pneumoniae, their potential to spread widely among patients necessitates molecular detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae implicated in Urinary Tract Infection. \nMethodology: A total of twelve (12) non-repeated clinical isolate of Escherichia coli (E1, E2, E3, E4, E5, E6, E7) and Klebsiella pneumoniae (K8, K9, K10, K11, K12) were selected based on their in vitro phenotypic resistant to carbapenem antibiotics from patients diagnosed with urinary tract infection at Alex Ekwueme Federal University Teaching Hospital, Abakaliki (AE-FEUTHA) Ebonyi Sate Nigeria. Escherichia coli and Klebsiella pneumoniae were further confirmed using standard routine microbiological technique for isolation and identification of bacteria. Escherichia coli and Klebsiella pneumoniae strains were further screen for carbapenemase-producing gene by PCR specific primer. \nResult: PCR analysis with specific primer for carbapenemase gene revealed the presence and predominant of blaKPC in Escherichia coli and Klebsiella pneumoniae 12(100 %) followed by blaNDM 11(91.7 %), blaIMP 7(58.3 %) and blaVIM 2(16.7) as the least carbapenemase-producing gene in Escherichia coli and Klebsiella pneumoniae. blaKPC was predominant in Escherichia coli 7(58.3 %) followed by blaNDM 6(50.0 %) and blaIMP 5(41.7 %) while both blaOXA and blaVIM (16.7 %) were the least detected carbapenemase gene. Klebsiella pneumoniae harbor high proportion of blaNDM and blaKPC both recording 5(41.7 %) followed by blaOXA and blaIMP both recording 2(16.7 %) but blaVIM gene was not identified in Klebsiella pneumoniae. \nConclusion: The current findings highlight the occurrence of carbapenemase-producing gene in Escherichia coli and Klebsiella pneumoniae implicated in UTI. Since these genes are carried on the bacteria plasmid there is a tendency of cross-species dissemination over time. The detection of carbapenemase-producing gene call for prompt epidemiological surveillance and preventive strategies to limit the spread of these carbapenemase resistant genetic determinant and the need for antibiotic susceptibility testing of available antibiotic agent.","PeriodicalId":166387,"journal":{"name":"Asian Journal of Research in Infectious Diseases","volume":"79 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Detection of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae Implicated in Urinary Tract Infection\",\"authors\":\"Onyinye Lovette Nomeh, Obodoechi Ijeoma Federica, Ofonmbuk Victor Joseph, Ezeh Chinonyelum Moneth, Rebecca Chinenye Ogba, Ohadoma Angela Nkechi, I. Peter, Peace Oluchi Akpu, C. I. Edemekong, I. Iroha\",\"doi\":\"10.9734/ajrid/2023/v12i1234\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and Objectives: Carbapenemase-producing bacteria are super bugs that make Urinary Tract Infections (UTIs) difficult to treat with drug of last resort such as carbapenem and other antibiotic thus limiting the treatment options. Carbapenemase production is increasing in clinical isolates of E. coli and K. pneumoniae, their potential to spread widely among patients necessitates molecular detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae implicated in Urinary Tract Infection. \\nMethodology: A total of twelve (12) non-repeated clinical isolate of Escherichia coli (E1, E2, E3, E4, E5, E6, E7) and Klebsiella pneumoniae (K8, K9, K10, K11, K12) were selected based on their in vitro phenotypic resistant to carbapenem antibiotics from patients diagnosed with urinary tract infection at Alex Ekwueme Federal University Teaching Hospital, Abakaliki (AE-FEUTHA) Ebonyi Sate Nigeria. Escherichia coli and Klebsiella pneumoniae were further confirmed using standard routine microbiological technique for isolation and identification of bacteria. Escherichia coli and Klebsiella pneumoniae strains were further screen for carbapenemase-producing gene by PCR specific primer. \\nResult: PCR analysis with specific primer for carbapenemase gene revealed the presence and predominant of blaKPC in Escherichia coli and Klebsiella pneumoniae 12(100 %) followed by blaNDM 11(91.7 %), blaIMP 7(58.3 %) and blaVIM 2(16.7) as the least carbapenemase-producing gene in Escherichia coli and Klebsiella pneumoniae. blaKPC was predominant in Escherichia coli 7(58.3 %) followed by blaNDM 6(50.0 %) and blaIMP 5(41.7 %) while both blaOXA and blaVIM (16.7 %) were the least detected carbapenemase gene. Klebsiella pneumoniae harbor high proportion of blaNDM and blaKPC both recording 5(41.7 %) followed by blaOXA and blaIMP both recording 2(16.7 %) but blaVIM gene was not identified in Klebsiella pneumoniae. \\nConclusion: The current findings highlight the occurrence of carbapenemase-producing gene in Escherichia coli and Klebsiella pneumoniae implicated in UTI. Since these genes are carried on the bacteria plasmid there is a tendency of cross-species dissemination over time. The detection of carbapenemase-producing gene call for prompt epidemiological surveillance and preventive strategies to limit the spread of these carbapenemase resistant genetic determinant and the need for antibiotic susceptibility testing of available antibiotic agent.\",\"PeriodicalId\":166387,\"journal\":{\"name\":\"Asian Journal of Research in Infectious Diseases\",\"volume\":\"79 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Research in Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9734/ajrid/2023/v12i1234\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Research in Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/ajrid/2023/v12i1234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
背景与目的:产碳青霉烯酶细菌是一种超级细菌,它使尿路感染难以用碳青霉烯类药物和其他抗生素等最后手段治疗,从而限制了治疗选择。大肠杆菌和肺炎克雷伯菌的临床分离株碳青霉烯酶产量正在增加,它们在患者中广泛传播的潜力需要对与尿路感染有关的产碳青霉烯酶的大肠杆菌和肺炎克雷伯菌进行分子检测。方法:从尼日利亚埃邦伊州Abakaliki Alex Ekwueme联邦大学教学医院(AE-FEUTHA)诊断为尿路感染的患者中筛选出12株非重复临床分离株大肠埃希菌(E1、E2、E3、E4、E5、E6、E7)和肺炎克雷伯菌(K8、K9、K10、K11、K12),根据其体外表型对碳青霉烯类抗生素耐药。采用标准常规微生物学技术分离鉴定大肠埃希菌和肺炎克雷伯菌。利用PCR特异性引物进一步筛选大肠杆菌和肺炎克雷伯菌产碳青霉烯酶基因。结果:碳青霉烯酶基因特异性引物PCR分析结果显示,blaKPC在大肠杆菌和肺炎克雷伯菌12中存在并优势表达(100%),其次是blandm11(91.7%)、blaim7(58.3%)和blavim2(16.7%),是大肠杆菌和肺炎克雷伯菌中产碳青霉烯酶最少的基因。碳青霉烯酶基因blaKPC在大肠杆菌7(58.3%)中含量最高,其次是blandm6(50.0%)和blaimp5 (41.7%), blaOXA和blaVIM(16.7%)含量最低。肺炎克雷伯菌中blaNDM和blaKPC基因比例较高,均为5个(41.7%),其次是blaxa和blaIMP基因,均为2个(16.7%),而blaVIM基因未在肺炎克雷伯菌中检测到。结论:目前的研究结果表明,碳青霉烯酶产生基因在大肠杆菌和肺炎克雷伯菌中与尿路感染有关。由于这些基因携带在细菌质粒上,随着时间的推移,有跨物种传播的趋势。碳青霉烯酶产生基因的检测需要及时开展流行病学监测和预防策略,以限制这些碳青霉烯酶耐药遗传决定因素的传播,并需要对现有抗生素进行药敏试验。
Detection of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae Implicated in Urinary Tract Infection
Background and Objectives: Carbapenemase-producing bacteria are super bugs that make Urinary Tract Infections (UTIs) difficult to treat with drug of last resort such as carbapenem and other antibiotic thus limiting the treatment options. Carbapenemase production is increasing in clinical isolates of E. coli and K. pneumoniae, their potential to spread widely among patients necessitates molecular detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae implicated in Urinary Tract Infection.
Methodology: A total of twelve (12) non-repeated clinical isolate of Escherichia coli (E1, E2, E3, E4, E5, E6, E7) and Klebsiella pneumoniae (K8, K9, K10, K11, K12) were selected based on their in vitro phenotypic resistant to carbapenem antibiotics from patients diagnosed with urinary tract infection at Alex Ekwueme Federal University Teaching Hospital, Abakaliki (AE-FEUTHA) Ebonyi Sate Nigeria. Escherichia coli and Klebsiella pneumoniae were further confirmed using standard routine microbiological technique for isolation and identification of bacteria. Escherichia coli and Klebsiella pneumoniae strains were further screen for carbapenemase-producing gene by PCR specific primer.
Result: PCR analysis with specific primer for carbapenemase gene revealed the presence and predominant of blaKPC in Escherichia coli and Klebsiella pneumoniae 12(100 %) followed by blaNDM 11(91.7 %), blaIMP 7(58.3 %) and blaVIM 2(16.7) as the least carbapenemase-producing gene in Escherichia coli and Klebsiella pneumoniae. blaKPC was predominant in Escherichia coli 7(58.3 %) followed by blaNDM 6(50.0 %) and blaIMP 5(41.7 %) while both blaOXA and blaVIM (16.7 %) were the least detected carbapenemase gene. Klebsiella pneumoniae harbor high proportion of blaNDM and blaKPC both recording 5(41.7 %) followed by blaOXA and blaIMP both recording 2(16.7 %) but blaVIM gene was not identified in Klebsiella pneumoniae.
Conclusion: The current findings highlight the occurrence of carbapenemase-producing gene in Escherichia coli and Klebsiella pneumoniae implicated in UTI. Since these genes are carried on the bacteria plasmid there is a tendency of cross-species dissemination over time. The detection of carbapenemase-producing gene call for prompt epidemiological surveillance and preventive strategies to limit the spread of these carbapenemase resistant genetic determinant and the need for antibiotic susceptibility testing of available antibiotic agent.